Translational Science 2021 Abstracts

Important Dates and Deadlines*

  • Abstract Submissions Open: October 1
  • Abstract Submission Deadline: December 2
  • Abstract Accept/Reject Notification: January 18

* Dates subject to change

Abstract Tracks

Review full list of tracks.

  • Basic Science
  • Commercialization/Entrepreneurship
  • Digital Health/Social Media
  • Evaluation
  • Mechanistic Basic to Clinical
  • Regulatory Science
  • Translational Science, Policy, & Health Outcomes Science
  • Clinical Epidemiology
  • Clinical Trial
  • Data Science/Biostatistics/Informatics
  • Health Equity & Community Engagement
  • Precision Medicine
  • Team Science
  • Education/Mentoring/Professional and Career Development
  • Dissemination and Implementation

Abstract Character Count

  • Objective/Goals: 300 characters
  • Methods/Study Population: 700 characters
  • Results/Anticipated Results: 700 characters
  • Discussion/Signficance of Impact: 300 characters

Presentation Type

  • All accepted abstracts will be presented as a poster. In addition, some of those abstracts will be selected for a platform presentation. If you do not wish to be considered for a platform presentation, select “Poster Only” in the submission form.
  • If your abstract has been accepted overall, but has not been accepted for an oral platform presentation, it will still be presented as a poster.
  • If you are a TL1 scholar, and select “Poster Only”, you will not be eligible for any TL1 awards. Only those who select “Platform and Poster Presentation” will be considered for a competitive oral presentation and poster awards.

JCTS Publication

The information you submit will be used to evaluate your abstract for inclusion in the Translational science 2021. It will additionally be used to evaluate your abstract for publication in the abstract issue of JCTS only if you have selected “Yes” in the submission form.

Disclosure/Conflict of Interest

Authors must disclose all financial interests and non-financial interests with industry or financial agencies within 3 years of submitting an abstract for consideration that might be perceived by a scientific reader or a member of the general public to be a potential conflict of interest. Potential sources of conflict include corporate appointments, consultant fees, research funding, stock ownership or other equity interests, or patent-licensing arrangements.

Abstract Review

  • After the submission site closes, completed abstracts will be peer reviewed.
  • All abstracts will be blinded for review, meaning the abstracts will be reviewed without knowledge of the author/s, institution/s or disclosure information.
  • Accepted abstracts will be selected as oral poster or poster only.

Other Information

  • In order to be considered for a BWF Travel Award, the primary author must be a pre-doctoral trainee and upload a CV.
  • When submitting an abstract, you may include up to nine (9) authors.

Co-Supported by: